![]()
|
|
||||||||
J. Biol. Chem., Vol. 266, Issue 32, 21331-21334, Nov, 1991
FA Sandhu, M Salim and SB Zain
The human beta-amyloid protein is deposited in senile plaques and in the
cerebro-vasculature of people with Alzheimer's disease and Down's syndrome.
The precise role of beta-amyloid in Alzheimer's disease pathology is
presently unknown. To study the properties of beta-amyloid in vivo, we
generated transgenic mice that harbor the gene for the carboxyl-terminal
100 amino acids of the human amyloid precursor protein, beginning with the
beta-amyloid region, under control of the JC viral early region promoter.
The mRNA is expressed exclusively in brain tissue. Further, we demonstrate
increased levels of beta-amyloid immunoreactivity on fixed brain tissue.
These animals will be useful as a model to study beta-amyloid deposition
and its consequences.
Expression of the human beta-amyloid protein of Alzheimer's disease specifically in the brains of transgenic mice
Department of Biochemistry, University of Rochester School of Medicine, New York 14642.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Hardy and G. Higgins Alzheimer's disease: the amyloid cascade hypothesis Science, April 10, 1992; 256(5054): 184 - 185. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |